Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 2/2016

01-06-2016 | Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

The Devastated Bladder Outlet in Cancer Survivors After Local Therapy for Prostate Cancer

Authors: Shyam Sukumar, Sean P. Elliott

Published in: Current Bladder Dysfunction Reports | Issue 2/2016

Login to get access

Abstract

Prostate cancer is common; this combined with the long life expectancy after treatment has sparked a growing emphasis on prostate cancer survivorship care. An important goal of such care is preserving quality of life through ameliorating the side effects of therapy. Posterior urethral stenosis (PUS) can occur as a complication of radical prostatectomy (RP) and radiation therapy (RT). Evaluation includes a history, physical exam, uroflowmetry, lab tests, cystoscopy, and radiological studies. PUS is initially managed with endoscopic techniques such as dilation or internal urethrotomy. Patients who fail such therapies can be offered surgical reconstruction. Continence is an important factor in the management of PUS. In some cases, particularly after radiotherapy, the outlet may not be salvageable, and a permanent indwelling catheter or urinary diversion may be the only options. We review the evaluation of patients with the devastated bladder outlet: those undergoing repeat endoscopic treatments, surgical reconstruction, or urinary diversion.
Literature
1.
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.CrossRefPubMed
2.
3.
Resnick MJ, Lacchetti C, Bergman J, et al. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. J Clin Oncol. 2015;33:1078–85.CrossRefPubMed
4.
Skolarus TA, Wolf AM, Erb NL, et al. American Cancer Society Prostate Cancer Survivorship Care Guidelines. CA Cancer J Clin. 2014;64:225–49.CrossRefPubMed
5.
6.
Johansson E, Steineck G, Holmberg L, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011;12:891–9.CrossRefPubMed
7.•
Jarosek SL, Virnig BA, Chu H, Elliott SP. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Eur Urol. 2015;67:273–80. An important publication detailing the long-term propensity weighted incidence of urinary toxicity in a large national cohort of patients receiving the various types of prostate cancer therapy.CrossRefPubMed
8.
Elliott SP, Meng MV, Elkin EP, et al. Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE. J Urol. 2007;178:529–34. discussion 534.CrossRefPubMed
9.
Borboroglu PG, Sands JP, Roberts JL, Amling CL. Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology. 2000;56:96–100.CrossRefPubMed
10.
Gillitzer R, Thomas C, Wiesner C, et al. Single center comparison of anastomotic strictures after radical perineal and radical retropubic prostatectomy. Urology. 2010;76:417–22.CrossRefPubMed
11.
Erickson BA, Meeks JJ, Roehl KA, et al. Bladder neck contracture after retropubic radical prostatectomy: incidence and risk factors from a large single-surgeon experience. BJU Int. 2009;104:1615–9.CrossRefPubMedPubMedCentral
12.
Hu JC, Gold KF, Pashos CL, et al. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003;21:401–5.CrossRefPubMed
13.
Thompson Jr IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA. 2006;296:2329–35.CrossRefPubMed
14.
Gandaglia G, Sammon JD, Chang SL, et al. Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era. J Clin Oncol. 2014;32:1419–26.CrossRefPubMed
15.
Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA. 2009;302:1557–64.CrossRefPubMed
16.
Kowalczyk KJ, Levy JM, Caplan CF, et al. Temporal national trends of minimally invasive and retropubic radical prostatectomy outcomes from 2003 to 2007: results from the 100% Medicare sample. Eur Urol. 2012;61:803–9.CrossRefPubMed
17.
Webb DR, Sethi K, Gee K. An analysis of the causes of bladder neck contracture after open and robot-assisted laparoscopic radical prostatectomy. BJU Int. 2009;103:957–63.CrossRefPubMed
18.
Ramsden AR, Chodak GW. Can leakage at the vesico-urethral anastomosis be predicted after radical retropubic prostatectomy? BJU Int. 2004;93:503–6.CrossRefPubMed
19.
Patil MB, Hannoun D, Reyblat P, Boyd SD. Total bladder and posterior urethral reconstruction: salvage technique for defunctionalized bladder with recalcitrant posterior urethral stenosis. J Urol. 2015;193:1649–54.CrossRefPubMed
20.
Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435–48.CrossRefPubMed
21.
Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181:956–62.CrossRefPubMedPubMedCentral
22.
Wiegel T, Bottke D, Steiner U, et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol. 2009;27:2924–30.CrossRefPubMed
23.
24.
Merrick GS, Butler WM, Tollenaar BG, et al. The dosimetry of prostate brachytherapy-induced urethral strictures. Int J Radiat Oncol Biol Phys. 2002;52:461–8.CrossRefPubMed
25.
Merrick GS, Butler WM, Wallner KE, et al. Risk factors for the development of prostate brachytherapy related urethral strictures. J Urol. 2006;175:1376–80. discussion 1381.CrossRefPubMed
26.
Ishiyama H, Hirayama T, Jhaveri P, et al. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Am J Clin Oncol. 2014;37:297–304.CrossRefPubMed
27.
Seymore CH, el-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys. 1986;12:1597–600.CrossRefPubMed
28.
Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233–9.CrossRefPubMed
29.
Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 2000;18:3904–11.PubMed
30.
Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1124–9.CrossRefPubMed
31.
Kowalczyk KJ, Gu X, Nguyen PL, et al. Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Urol Oncol. 2014;32:303–8.CrossRefPubMed
32.
Liberman D, Jarosek S, Virnig BA, et al. The patient burden of bladder outlet obstruction after prostate cancer treatment. J Urol. 2015.
33.
Sullivan L, Williams SG, Tai KH, et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91:232–6.CrossRefPubMed
34.
Barret E, Ahallal Y, Sanchez-Salas R, et al. Morbidity of focal therapy in the treatment of localized prostate cancer. Eur Urol. 2013;63:618–22.CrossRefPubMed
35.
Muto S, Yoshii T, Saito K, et al. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38:192–9.CrossRefPubMed
36.
Nieder AM, Porter MP, Soloway MS. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. J Urol. 2008;180:2005–9. discussion 2009–2010.CrossRefPubMed
37.
Theodoros C, Katsifotis C, Stournaras P, et al. Abdomino-perineal repair of recurrent and complex bladder neck-prostatic urethra contractures. Eur Urol. 2000;38:734–40. discusssion 740–731.CrossRefPubMed
38.••
Herschorn S, Elliott S, Coburn M, et al. SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer. Urology. 2014;83:S59–70. This is a consensus statement on the contemporary management of prostate cancer therapy related posterior urethral stenosis and is the product of a collaborative between the Société Internationale d’Urologie and the International Consultation on Urologic Diseases.CrossRefPubMed
39.
Herschorn S, Carrington E. S-shaped coaxial dilators for male urethral strictures. Urology. 2007;69:1199–201.CrossRefPubMed
40.
Giesy JD, Finn JC, Hermann GD, et al. Coaxial balloon dilation and calibration of urethral strictures. Am J Surg. 1984;147:611–4.CrossRefPubMed
41.
Geary ES, Dendinger TE, Freiha FS, Stamey TA. Incontinence and vesical neck strictures following radical retropubic prostatectomy. Urology. 1995;45:1000–6.CrossRefPubMed
42.
Park R, Martin S, Goldberg JD, Lepor H. Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence. Urology. 2001;57:742–6.CrossRefPubMed
43.
Surya BV, Provet J, Johanson KE, Brown J. Anastomotic strictures following radical prostatectomy: risk factors and management. J Urol. 1990;143:755–8.PubMed
44.
Dalkin BL. Endoscopic evaluation and treatment of anastomotic strictures after radical retropubic prostatectomy. J Urol. 1996;155:206–8.CrossRefPubMed
45.
Popken G, Sommerkamp H, Schultze-Seemann W, et al. Anastomotic stricture after radical prostatectomy. Incidence, findings and treatment. Eur Urol. 1998;33:382–6.CrossRefPubMed
46.
Vanni AJ, Zinman LN, Buckley JC. Radial urethrotomy and intralesional mitomycin C for the management of recurrent bladder neck contractures. J Urol. 2011;186:156–60.CrossRefPubMed
47.
Elliott DS, Boone TB. Combined stent and artificial urinary sphincter for management of severe recurrent bladder neck contracture and stress incontinence after prostatectomy: a long-term evaluation. J Urol. 2001;165:413–5.CrossRefPubMed
48.
McNamara ER, Webster GD, Peterson AC. The UroLume stent revisited: the Duke experience. Urology. 2013;82:933–6.CrossRefPubMed
49.
Magera Jr JS, Inman BA, Elliott DS. Outcome analysis of urethral wall stent insertion with artificial urinary sphincter placement for severe recurrent bladder neck contracture following radical prostatectomy. J Urol. 2009;181:1236–41.CrossRefPubMed
50.
Mundy AR, Andrich DE. Posterior urethral complications of the treatment of prostate cancer. BJU Int. 2012;110:304–25.CrossRefPubMed
51.
Matsushita K, Ginsburg L, Mian BM, et al. Pubovesical fistula: a rare complication after treatment of prostate cancer. Urology. 2012;80:446–51.CrossRefPubMed
52.
Wessells H, Morey AF, McAninch JW. Obliterative vesicourethral strictures following radical prostatectomy for prostate cancer: reconstructive armamentarium. J Urol. 1998;160:1373–5.CrossRefPubMed
53.
Elliott SP, McAninch JW, Chi T, et al. Management of severe urethral complications of prostate cancer therapy. J Urol. 2006;176:2508–13.CrossRefPubMed
54.
Song J, Eswara J, Brandes SB. Postprostatectomy anastomosis stenosis: a systematic review. Urology. 2015;86:211–8.CrossRefPubMed
55.
Pfalzgraf D, Beuke M, Isbarn H, et al. Open retropubic reanastomosis for highly recurrent and complex bladder neck stenosis. J Urol. 2011;186:1944–7.CrossRefPubMed
56.
Simonato A, Gregori A, Lissiani A, Carmignani G. Two-stage transperineal management of posterior urethral strictures or bladder neck contractures associated with urinary incontinence after prostate surgery and endoscopic treatment failures. Eur Urol. 2007;52:1499–504.CrossRefPubMed
57.
Meeks JJ, Brandes SB, Morey AF, et al. Urethroplasty for radiotherapy induced bulbomembranous strictures: a multi-institutional experience. J Urol. 2011;185:1761–5.CrossRefPubMed
58.•
Hofer MD, Zhao LC, Morey AF, et al. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease. J Urol. 2014;191:1307–12. The largest reported cohort of patients undergoing urethroplasty for radiotherapy-related posterior urethral stenosis from three major academic institutions.CrossRefPubMed
59.
Redshaw JD, Elliott SP, Rosenstein DI, et al. Procedures needed to maintain functionality of adult continent catheterizable channels: a comparison of continent cutaneous ileal cecocystoplasty with tunneled catheterizable channels. J Urol. 2014;192:821–6.CrossRefPubMed
Metadata
Title
The Devastated Bladder Outlet in Cancer Survivors After Local Therapy for Prostate Cancer
Authors
Shyam Sukumar
Sean P. Elliott
Publication date
01-06-2016
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 2/2016
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-016-0355-6

Other articles of this Issue 2/2016

Current Bladder Dysfunction Reports 2/2016 Go to the issue

Pelvic Pain (R Moldwin and S Bahlani, Section Editors)

The Role of Urinary Diversion for Bladder Pain

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Influence of Age and Obesity on 5α-Reductase 2 Gene Expression

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Management of End-Stage Radiation Cystitis in the Cancer Survivor

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

Statin Medications and Development and Progression of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms

BPH-Related Voiding Dysfunction (R Lee, Section Editor)

An Outcomes Review of Minimally Invasive Transurethral Convective Water Vapor Energy (WAVE) Therapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Cancer-Associated Voiding Dysfunction (A Peterson, Section Editor)

Urinary Dysfunction in the Rectal Cancer Survivor